<unk>  is a antidiabetic , endocrine metabolic-hypoglycemic agent  and meglitinide that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia and upper respiratory infection.
Nateglinide
Linagliptin
Glyburide
Pioglitazone
Vildagliptin
Liraglutide
Rosiglitazone
Canagliflozin